Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment.
Did you know?
15% of the couples are globally affected by infertility, with male-factor accounting for 50% of the global infertility.
New SmiLe member Spermosens has analysis for childless couples (2020-08-18)
223 63 Lund
Sign up to our newsletter
Download our Press kit